Tissera, Inc. Reports Successful Equity Financing Designed For Completion Of Pre-Clinical Studies On Primate Diabetic Models
HERZLIYA, Israel--(BUSINESS WIRE)--Tissera, Inc. (OTCBB:TSSR) reports that it has completed an additional equity financing round amounting to a gross of $1,650,000 before related expenses. This sum was raised from existing Tissera institutional investors.